GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » Ending Cash Position

Bio View (XTAE:BIOV) Ending Cash Position : ₪13.55 Mil (As of Jun. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Bio View Ending Cash Position?

Bio View's Ending Cash Position for the quarter that ended in Jun. 2024 was ₪13.55 Mil.

Bio View's quarterly Ending Cash Position declined from Jun. 2023 (₪18.49 Mil) to Dec. 2023 (₪15.69 Mil) and declined from Dec. 2023 (₪15.69 Mil) to Jun. 2024 (₪13.55 Mil).

Bio View's annual Ending Cash Position increased from Dec. 2021 (₪19.22 Mil) to Dec. 2022 (₪19.44 Mil) but then declined from Dec. 2022 (₪19.44 Mil) to Dec. 2023 (₪15.69 Mil).

Bio View Ending Cash Position Historical Data

The historical data trend for Bio View's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bio View Ending Cash Position Chart

Bio View Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Ending Cash Position
Get a 7-Day Free Trial Premium Member Only Premium Member Only 18.74 17.24 19.22 19.44 15.69

Bio View Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Ending Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 19.48 -0.04 18.49 15.69 13.55

Bio View Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Bio View's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position= Beginning Cash Position+Net Change in Cash
=19.437+-3.747
=15.69

Bio View's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position=Beginning Cash Position+Net Change in Cash
=15.69+-2.141
=13.55

Bio View Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Bio View's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Bio View Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Bio View Ltd (XTAE:BIOV) » Definitions » Ending Cash Position
Comparable Companies
XTAE:ALMD XTAE:ENDY XTAE:BCUR XTAE:EMTC-M XTAE:EMITF-M XTAE:HUMX XTAE:EFNC-M ABT SYK BSX MDT XTER:SHL EW SZSE:300760 DXCM XAMS:PHIA ZBH STE XSWX:SOON PODD
Traded in Other Exchanges
N/A
Address
3 Pekeris Street, Rehovot, ISR, 7670203
Website
http://www.bioview.co.il
Bio View Ltd is an Israel based company engaged in the research, development, manufacture, marketing, and sale of computerized systems for identification of rate cells and test for detection of cancer. It manufactures and markets automated cell imaging and analysis solutions for use in cytology, cytogenetic, pathology clinical and research laboratories. Geographically, the group has its business presence in Israel, USA, and other countries, of which majority of the revenue is derived from the USA.

Bio View Headlines

No Headlines